Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125552601 | 12555260 | 1 | I | 20160602 | 20160706 | 20160714 | 20160714 | EXP | US-JNJFOC-20160706025 | JANSSEN | 69.00 | YR | E | F | Y | 83.20000 | KG | 20160714 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125552601 | 12555260 | 1 | PS | XARELTO | RIVAROXABAN | 1 | Oral | U | U | 22406 | TABLET | ||||||||
125552601 | 12555260 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | Y | 0 | 50 | MG | CAPSULE | |||||||
125552601 | 12555260 | 3 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | Y | 0 | 50 | MG | CAPSULE | |||||||
125552601 | 12555260 | 4 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | U | 0 | FILM COATED TABLET | |||||||||
125552601 | 12555260 | 5 | SS | AMLODIPINE BESILATE | AMLODIPINE BESYLATE | 1 | Oral | U | 0 | FILM COATED TABLET | |||||||||
125552601 | 12555260 | 6 | SS | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | Oral | U | 0 | UNSPECIFIED | |||||||||
125552601 | 12555260 | 7 | SS | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | Oral | U | 0 | TABLET | |||||||||
125552601 | 12555260 | 8 | SS | PHENERGAN | PROMETHAZINE HYDROCHLORIDE | 1 | Oral | U | 0 | UNSPECIFIED | |||||||||
125552601 | 12555260 | 9 | SS | BUPROPION. | BUPROPION | 1 | Oral | U | 0 | UNSPECIFIED | |||||||||
125552601 | 12555260 | 10 | SS | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Oral | U | 0 | UNSPECIFIED | |||||||||
125552601 | 12555260 | 11 | SS | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Oral | U | 0 | UNSPECIFIED | |||||||||
125552601 | 12555260 | 12 | SS | RITALIN | METHYLPHENIDATE HYDROCHLORIDE | 1 | Oral | U | 0 | UNSPECIFIED |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125552601 | 12555260 | 1 | Embolism |
125552601 | 12555260 | 2 | Salivary gland cancer |
125552601 | 12555260 | 3 | Salivary gland cancer |
125552601 | 12555260 | 4 | Hyperlipidaemia |
125552601 | 12555260 | 5 | Hypertension |
125552601 | 12555260 | 6 | Depression |
125552601 | 12555260 | 7 | Hypothyroidism |
125552601 | 12555260 | 8 | Nausea |
125552601 | 12555260 | 9 | Depression |
125552601 | 12555260 | 10 | Depression |
125552601 | 12555260 | 11 | Nausea |
125552601 | 12555260 | 12 | Fatigue |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125552601 | 12555260 | HO |
125552601 | 12555260 | DS |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125552601 | 12555260 | Bundle branch block right | |
125552601 | 12555260 | Mouth haemorrhage | |
125552601 | 12555260 | Sinus bradycardia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125552601 | 12555260 | 1 | 20160517 | 0 | ||
125552601 | 12555260 | 2 | 20160411 | 20160509 | 0 | |
125552601 | 12555260 | 3 | 20160523 | 20160602 | 0 | |
125552601 | 12555260 | 4 | 20130101 | 0 | ||
125552601 | 12555260 | 5 | 20120101 | 0 | ||
125552601 | 12555260 | 6 | 20150101 | 0 | ||
125552601 | 12555260 | 7 | 19900101 | 0 | ||
125552601 | 12555260 | 8 | 20160516 | 0 | ||
125552601 | 12555260 | 9 | 20151001 | 0 | ||
125552601 | 12555260 | 10 | 20150101 | 0 | ||
125552601 | 12555260 | 11 | 20160516 | 0 | ||
125552601 | 12555260 | 12 | 20160411 | 0 |